Stemcentrx

Rova-T: the story of AbbVie’s multi-billion dollar failure
Pharmaforum
Wed, 09/4/19 - 10:12 am
AbbVie
lung cancer
M&A
Stemcentrx
Rova-T
First AbbVie chopped a PhIII, then they wrote off $4B in book value. Now 178 Stemcentrx workers are getting the ax
Endpoints
Thu, 03/28/19 - 07:46 pm
AbbVie
Stemcentrx
layoffs
AbbVie records $4B impairment on Stemcentrx deal
BioCentury
Sun, 01/6/19 - 07:49 pm
AbbVie
Stemcentrx
M&A
When Will They Learn? 4 Huge Biotech Blowups
Motley Fool
Thu, 03/29/18 - 09:24 pm
biotech
AstraZeneca
ZS-9
drug manufacturing
Alexion
Synageva
Merck
Cubist Pharmaceuticals
AbbVie
Rova-T
Stemcentrx
How AbbVie Is Attacking Tumors at Their Roots
Motley Fool
Wed, 03/29/17 - 09:06 am
AbbVie
solid tumors
cancer
stem cells
Stemcentrx
Rova-T
2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals
Endpoints
Wed, 02/22/17 - 11:43 am
M&A
Shire
Baxalta
Pfizer
Medivation
Mylan
Meda
AbbVie
Stemcentrx
Anacor
Why AbbVie Expects Rova-T to Earn so Big in Peak Sales
Marketwatch
Sun, 07/10/16 - 12:07 pm
AbbVie
Rova-T
Stemcentrx
lung cancer
What AbbVie Bought for $5.8 Billion
Motley Fool
Mon, 06/6/16 - 11:25 am
AbbVie
Stemcentrx
M&A
Rova-T
lung cancer
How Biotech Companies Expecting M&A Deals Can Offer High Returns
Investopedia
Wed, 05/18/16 - 11:06 am
M&A
biotech
AbbVie
Abbott Labs
Stemcentrx
St. Jude Medical
AbbVie agrees to buy Peter Thiel-backed biotech Stemcentrx
Marketwatch
Thu, 04/28/16 - 09:42 am
AbbVie
Stemcentrx
M&A
Biotech unicorn Stemcentrx is reportedly up for a multibillion-dollar sale
Fierce Biotech
Mon, 03/14/16 - 05:52 pm
Stemcentrx
M&A